Stay updated on Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.
Latest updates to the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check23 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check52 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check74 days agoChange DetectedThe website has added new features for data download options, while several key government health-related links have been removed.SummaryDifference14%
Stay in the know with updates to Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.